NCT07868198

Brief Summary

Today, there is a shortage of tissues such as corneas for a variety of reasons. However, it is possible to harvest tissues from people who are usually excluded from donation, particularly cancer diagnosed, by recruiting them into palliative care units. Corneal transplantation is a surgical procedure designed to improve the vision of many persons. A number of diseases now require corneal transplants, such as keratoconus. As with other organs, the shortage of donors remains a major obstacle to the use of this technique, a shortage which became much more acute during the health crisis linked to the pandemic caused by the SARS-CoV-2 virus. In 2022, 10615 participants were waiting for a transplant, but only 46.3% of them received one. Cornea removal differs from the removal of other organs. Firstly, there are fewer contra-indications. It can be performed on persons with chronic conditions that would usually exclude them from receiving other organs, such as cancer. As the cornea is not vascularised, the risk of damage is considered to be zero, except in cases of cancers of cerebral neurological origin or melanoma. Secondly, the donor's remains can be preserved for up to 24 hours after death. This makes it possible to recruit care services that are not usually involved in organ transplants, as these services provide new potential donor recruitment resources. This includes palliative care units. There is currently no French literature on corneal donation specifically in palliative care units. There is a lack of data on the factors that encourage or hinder donation. Based on our experience of corneal donation in our palliative care unit since 2020, the investigators are conducting a clinical study to evaluate the factors that facilitate or impede corneal donation in our hospital palliative care unit.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Feb 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Feb 2025Mar 2028

Study Start

First participant enrolled

February 27, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2025

Completed
10 months until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

2.8 years

First QC Date

December 4, 2025

Last Update Submit

October 5, 2026

Conditions

Keywords

Tissue donationCorneal transplantationPalliative care unit

Outcome Measures

Primary Outcomes (1)

  • Biographical, Care Experience, and Organ donation attitude characteristics as assessed by structured questionnaires.

    Data collected include biographical and social characteristics of the relative, perceived quality of care in the palliative care unit, experience of being approached regarding corneal donation, and attitudes toward organ and tissue donation.

    Enrolment visit and/or month 3

Secondary Outcomes (3)

  • Relatives' perceptions of Cornea Donation Requests following death in the Palliative Care Unit assessed by semi-structured interview.

    Enrolment visit and/or month 3

  • Perceptions of Corneal donation following death in a Palliative Care Unit assessed by structured questionnaire.

    Enrolment visit and/or month 3

  • Questionnaire-Based characteristics of relatives opposed and not opposed to Corneal Donation.

    Month 39

Study Arms (2)

Relatives agree for the corneal donation

Relatives disagree for the corneal donation

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The source population concerned by this study corresponds to the relatives of the deceased person who has been treated in the palliative care unit, limited to 3 relatives.

You may qualify if:

  • Relative or confidant over 18 years of age.
  • Relative or confidant has received written and oral information on the conditions for participation in this study.
  • Relative or confidant has signed an informed consent form.

You may not qualify if:

  • Confidant person who does not speak or read French.
  • Confidant person with a sensory deficit that makes it impossible to carry out an interview.
  • Confidant person under protective supervision (guardianship, curatorship, or safeguard of justice.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Diaconesses Croix Saint-Simon

Paris, Paris, 75012, France

RECRUITING

MeSH Terms

Conditions

Corneal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Roger THAY, Doctor

    Groupe Hospitalier Diaconesses Croix Saint-Simon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Djazia BOUZELMAT, Clinical Research Assistant

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 4, 2025

First Posted

October 9, 2026

Study Start

February 27, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

March 31, 2028

Last Updated

October 9, 2026

Record last verified: 2026-10

Locations